Literature DB >> 34385297

Providing an acute oncology service during the COVID-19 pandemic.

Shanthini M Crusz1,2, Peter E Hall3,2, Kate Earwicker3, Sue Dexter3, Gemma Patel-Walker3, Thomas Powles3, Nikolaos Diamantis3.   

Abstract

The COVID-19 pandemic has led to adaptations being made to all aspects of the NHS, including general practice, acute medical specialties and oncology. This has presented unique challenges to acute oncology services (AOSs) in how to provide continuity of care while maintaining the safety of patients and staff. We describe the experience of the AOS team at Barts Health NHS Trust, working across three acute hospitals in east London. Changes to the service due to COVID-19 included increased remote reviews and referrals to the specialist oncology cancer acute assessment unit. The patient population reviewed in April 2020 (at the initial peak of the pandemic in the UK) was markedly different to one reviewed in April 2019, with 55% more patients presenting with a new diagnosis of cancer via an emergency route. Finally, we suggest changes to AOSs for future waves of the pandemic. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  SARS-CoV-2; cancer services; coronavirus; pandemic; systemic anti-cancer therapy

Mesh:

Year:  2021        PMID: 34385297      PMCID: PMC8439511          DOI: 10.7861/clinmed.2020-0693

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  6 in total

1.  Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers.

Authors:  G A Abel; J Shelton; S Johnson; L Elliss-Brookes; G Lyratzopoulos
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

2.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Authors:  Nicole M Kuderer; Toni K Choueiri; Dimpy P Shah; Yu Shyr; Samuel M Rubinstein; Donna R Rivera; Sanjay Shete; Chih-Yuan Hsu; Aakash Desai; Gilberto de Lima Lopes; Petros Grivas; Corrie A Painter; Solange Peters; Michael A Thompson; Ziad Bakouny; Gerald Batist; Tanios Bekaii-Saab; Mehmet A Bilen; Nathaniel Bouganim; Mateo Bover Larroya; Daniel Castellano; Salvatore A Del Prete; Deborah B Doroshow; Pamela C Egan; Arielle Elkrief; Dimitrios Farmakiotis; Daniel Flora; Matthew D Galsky; Michael J Glover; Elizabeth A Griffiths; Anthony P Gulati; Shilpa Gupta; Navid Hafez; Thorvardur R Halfdanarson; Jessica E Hawley; Emily Hsu; Anup Kasi; Ali R Khaki; Christopher A Lemmon; Colleen Lewis; Barbara Logan; Tyler Masters; Rana R McKay; Ruben A Mesa; Alicia K Morgans; Mary F Mulcahy; Orestis A Panagiotou; Prakash Peddi; Nathan A Pennell; Kerry Reynolds; Lane R Rosen; Rachel Rosovsky; Mary Salazar; Andrew Schmidt; Sumit A Shah; Justin A Shaya; John Steinharter; Keith E Stockerl-Goldstein; Suki Subbiah; Donald C Vinh; Firas H Wehbe; Lisa B Weissmann; Julie Tsu-Yu Wu; Elizabeth Wulff-Burchfield; Zhuoer Xie; Albert Yeh; Peter P Yu; Alice Y Zhou; Leyre Zubiri; Sanjay Mishra; Gary H Lyman; Brian I Rini; Jeremy L Warner
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

3.  COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.

Authors:  Lennard Yw Lee; Jean-Baptiste Cazier; Vasileios Angelis; Roland Arnold; Vartika Bisht; Naomi A Campton; Julia Chackathayil; Vinton Wt Cheng; Helen M Curley; Matthew W Fittall; Luke Freeman-Mills; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin Jx Lee; Rebecca J Lee; Sophie E McGrath; Christopher P Middleton; Nirupa Murugaesu; Thomas Newsom-Davis; Alicia Fc Okines; Anna C Olsson-Brown; Claire Palles; Yi Pan; Ruth Pettengell; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Thomas Starkey; Chris D Turnbull; Csilla Várnai; Nadia Yousaf; Rachel Kerr; Gary Middleton
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

4.  Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.

Authors:  Amit Sud; Bethany Torr; Michael E Jones; John Broggio; Stephen Scott; Chey Loveday; Alice Garrett; Firza Gronthoud; David L Nicol; Shaman Jhanji; Stephen A Boyce; Matthew Williams; Elio Riboli; David C Muller; Emma Kipps; James Larkin; Neal Navani; Charles Swanton; Georgios Lyratzopoulos; Ethna McFerran; Mark Lawler; Richard Houlston; Clare Turnbull
Journal:  Lancet Oncol       Date:  2020-07-20       Impact factor: 41.316

5.  Emergency presentation of cancer and short-term mortality.

Authors:  S McPhail; L Elliss-Brookes; J Shelton; A Ives; M Greenslade; S Vernon; E J A Morris; M Richards
Journal:  Br J Cancer       Date:  2013-09-17       Impact factor: 7.640

6.  Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Authors:  David J Pinato; Alberto Zambelli; Juan Aguilar-Company; Mark Bower; Christopher Sng; Ramon Salazar; Alexia Bertuzzi; Joan Brunet; Ricard Mesia; Elia Segui; Federica Biello; Daniele Generali; Salvatore Grisanti; Gianpiero Rizzo; Michela Libertini; Antonio Maconi; Nadia Harbeck; Bruno Vincenzi; Rossella Bertulli; Diego Ottaviani; Anna Carbo; Riccardo Bruna; Sarah Benafif; Andrea Marrari; Rachel Wuerstlein; M Carmen Carmona-Garcia; Neha Chopra; Carlo Tondini; Oriol Mirallas; Valeria Tovazzi; Marta Betti; Salvatore Provenzano; Vittoria Fotia; Claudia Andrea Cruz; Alessia Dalla Pria; Francesca D'Avanzo; Joanne S Evans; Nadia Saoudi-Gonzalez; Eudald Felip; Myria Galazi; Isabel Garcia-Fructuoso; Alvin J X Lee; Thomas Newsom-Davis; Andrea Patriarca; David Garcia-Illescas; Roxana Reyes; Palma Dileo; Rachel Sharkey; Yien Ning Sophia Wong; Daniela Ferrante; Javier Marco-Hernandez; Anna Sureda; Clara Maluquer; Isabel Ruiz-Camps; Gianluca Gaidano; Lorenza Rimassa; Lorenzo Chiudinelli; Macarena Izuzquiza; Alba Cabirta; Michela Franchi; Armando Santoro; Aleix Prat; Josep Tabernero; Alessandra Gennari
Journal:  Cancer Discov       Date:  2020-07-31       Impact factor: 39.397

  6 in total
  1 in total

1.  In response to crisis, is versatility a reward or a necessity.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.